This PROFITABLE Cancer Stock Has 10x Potential



Издатель
Novocure stock is a profitable medical device company that has been a home-run stock for early investors. But is novocure stock a buy? In this nvcr stock analysis video, Brian Feroldi and Brian Stoffel take nvcr stock through their investing frameworks to find out.

Want to follow our portfolios on Stockcard: https://stockcard.io?utm_medium=YouTube&utm_source=Video&utm_campaign=antifragile

Use promo code "antifragile" for 10% off!

◾Brian Feroldi's Quality Checklist portfolio: https://stockcard.io/portfoliostore/brian_quality?utm_medium=YouTube&utm_source=Video&utm_campaign=ShortVideo
◾Brian Stoffel's Anti-Fragile portfolio: https://stockcard.io/portfoliostore/anti_fragile?utm_medium=YouTube&utm_source=Video&utm_campaign=ShortVideo
◾Brian Feroldi's Anti-Portfolio: https://stockcard.io/portfoliostore/brian_antiportfolio?utm_medium=YouTube&utm_source=Video&utm_campaign=ShortVideo
◾Brian Stoffel's Fragile Portfolio: https://stockcard.io/portfoliostore/fragile?utm_medium=YouTube&utm_source=Video&utm_campaign=ShortVideo

Категория
Усилители
Комментариев нет.